Strategies developed by bacteria and virus for protection from the human complement system

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 5, 2004, Pages 479-496

  Blom, A M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Bordetella pertussis; C4b binding protein; Candida albicans; Complement; Complement inhibitors; Escherichia coli K1; Kaposi sarcoma associated herpesvirus (KSHV); Moraxella catharralis; Neisseria gonorrhoeae; Streptococcus pyogenes

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT INHIBITOR; SERINE PROTEINASE; ZINC ION;

BORDETELLA PERTUSSIS; CANDIDA ALBICANS; COMPLEMENT SYSTEM; CONFERENCE PAPER; ENZYME INHIBITION; ESCHERICHIA COLI; HUMAN HERPESVIRUS 8; MOLECULAR MODEL; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; STREPTOCOCCUS PYOGENES; VIRULENCE;

BORDETELLA; BORDETELLA PERTUSSIS; CANDIDA; CANDIDA ALBICANS; ESCHERICHIA COLI; HERPESVIRIDAE; HUMAN HERPESVIRUS 8; MORAXELLA CATARRHALIS; NEISSERIA; NEISSERIA GONORRHOEAE; STREPTOCOCCUS PYOGENES;

EID: 4043120470     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410002904     Document Type: Conference Paper

References (91)

1. Walport MJ. Complement. Part II. N Engl J Med 2001; 344: 1140-4.
2. Walport MJ. Complement. Part I. N Engl J Med 2001; 344: 1058-66.
3. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000; 37: 1141-9.
4. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-3.
5. Kirkitadze MD, Barlow PN. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 2001; 180: 146-61.
6. Barlow PN, Steinkasserer A, Norman DG, Kieffer B, Wiles AP, Sim RB, Campbell ID. Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol 1993; 232: 268-84.
7. Smith SA, Krishnasamy G, Murthy KH, Cooper A, Bromek K, Barlow PN, Kotwal GJ. Vaccinia virus complement control protein is monomeric, and retains structural and functional integrity after exposure to adverse conditions. Biochim Biophys Acta 2002; 1598: 55-64.
8. Kask L, Villoutreix BO, Steen M, Ramesh B, Dahlback B, Blom AM. Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H. Protein Sci 2004; 13: 1356-64.
9. Hourcade D, Garcia AD, Post TW, Taillon Miller P, Holers VM, Wagner LM, Bora NS, Atkinson JP. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics 1992; 12: 289-300.
10. Morgan BP, Walport MJ. Complement deficiency and disease. Immunol Today 1991; 12: 301-6.
11. Webb JH, Blom AM, Dahlbäck B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J Immunol 2002; 169: 2580-6.
12. Brodeur S, Angelini F, Bacharier LB, Blom AM, Mizoguchi E, Fujiwara H, Dahlback B, Plebani A, Tsitsikov E, Geha RS. C4b-binding protein (C4BP) activates B cells through the CD40 Receptor. Immunity 2003; 18: 837-48.
13. Trapp RG, Fletcher M, Forristal J, West CD. C4 binding protein deficiency in a patient with atypical Behcet's disease. J Rheumatol 1987; 14: 135-8.
14. Kask L, Hillarp A, Ramesh B, Dahlbäck B, Blom AM. Structural requirements for the intra-cellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 2002; 41: 9349-57.
15. Blom AM, Kask L, Dahlbäck B. Structural requirements for the complement regulatory activities of C4BP. J Biol Chem 2001; 276: 27136-44.
16. Webb JH, Villoutreix BO, Dahlback B, Blom AM. Localization of a hydrophobic binding site for anticoagulant protein S on the beta -chain of complement regulator C4b-binding protein. J Biol Chem 2001; 276: 4330-7.
17. Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89: 307-13.
18. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2: 285-314.
19. Frithz E, Heden LO, Lindahl G. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol Microbiol 1989; 3: 1111-9.
20. Heath DG, Cleary PP. Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci USA 1989; 86: 4741-5.
21. Johnsson E, Andresson G, Lindahl G, Heden LO. Identification of the IgA-binding region in Streptococcal protein Arp. J Immunol 1994; 153: 3557-64.
22. Stenberg L, O'Toole PW, Mestecky J, Lindahl G. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 1994; 269: 13458-64.
23. Kotarsky H, Hellwage J, Johnsson E, Skerka C, Svensson HG, Lindahl G, Sjobring U, Zipfel PF. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol 1998; 160: 3349-54.
24. Katerov V, Andreev A, Schalen C, Totolian AA. Protein F, a fibronectin-binding protein of Streptococcus pyogenes, also binds human fibrinogen: isolation of the protein and mapping of the binding region. Part I. Microbiology 1998; 144: 119-26.
25. Frick IM, Akesson P, Cooney J, Sjobring U, Schmidt KH, Gomi H, Hattori S, Tagawa C, Kishimoto F, Bjorck L. Protein H - a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin. Mol Microbiol 1994; 12: 143-51.
26. Thern A, Stenberg L, Dahlbäck B, Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol 1995; 154: 375-86.
27. Johnsson E, Them A, Dahlbäck B, Heden LO, Wikström M, Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol 1996; 157: 3021-9.
28. Accardo P, Sanchez Corral P, Criado O, Garcia E, Rodriguez de Cordoba S. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J Immunol 1996; 157: 4935-9.
29. Blom AM, Berggård K, Webb JH, Lindahl G, Villoutreix BO, Dahlbäck B. Human C4b-binding protein has overlapping but not identical binding sites for C4b and streptococcal M proteins. J Immunol 2000; 164: 5328-36.
30. Blom AM, Webb J, Villoutreix BO, Dahlbäck B. A cluster of positively charged amino acids in the N-terminal modules of the C4BP α-chain is crucial for C4b binding and factor I cofactor function. J Biol Chem 1999; 274: 19237-45.
31. Åkerström B, Lindqvist A, Lindahl G. Binding properties of protein Arp, a bacterial IgA-receptor. Mol Immunol 1991; 28: 349-57.
32. Morfeldt E, Berggard K, Persson J, Drakenberg T, Johnsson E, Lindahl E, Linse S, Lindahl G. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J Immunol 2001; 167: 3870-7.
33. Carlsson F, Berggård K, Stalhammar-Carlemalm M, Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med 2003; 198: 1057-68.
34. Berggård K, Johnsson E, Mooi FR, Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun 1997; 65: 3638-43.
35. Berggård K, Lindahl G, Dahlbäck B, Blom AM. Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur J Immunol 2001; 31: 2771-80.
36. Blom AM, Foltyn-Zadura A, Villoutreix BO, Dahlbäck B. Positively charged amino acids at the interface between α-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Mol Immunol 2000; 37: 445-53.
37. Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, Rice PA. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 1998; 187: 743-52.
38. Ram S, McQuillen DP, Gulati S, Elkins C, Pangburn MK, Rice PA. Binding of complement factor H to loop 5 of porin protein IA: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med 1998; 4: 671-80.
39. Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Monks BG, O'Connell C, Boden R, Elkins C, Pangburn MK, Dahlbäck B, Rice PA. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 2001; 193: 281-96.
40. Blom AM, Rytkönen A, Vasquez P, Lindahl G, Dahlbäck B, Jonsson A-B. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4b-binding protein. J Immunol 2001; 166: 6764-70.
41. Kellogg DS, Cohen IR, Norins LC, Schroeter AL, Reising G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol 1968; 96: 596-605.
42. Swanson J, Robbins K, Barrera O, Corwin D, Boslego J, Ciak J, Blake M, Koomey JM. Gonococcal pilin variants in experimental gonorrhea. J Exp Med 1987; 165: 1344-57.
43. Jonsson A-B, Nyberg G, Normark S. Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J 1991; 10: 477-88.
44. Jonsson A-B, Pfeifer J, Normark S. Neisseria gonorrhoeae PilC expression provides a selective mechanism for structural diversity of pili. Proc Natl Acad Sci USA 1992; 89: 3204-8.
45. Källström H, Liszewski MK, Atkinson JP, Jonsson A-B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997; 25: 639-47.
46. Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL, Cross AS. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest 1992; 90: 897-905.
47. Weiser JN, Gotschlich EC. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 1991; 59: 2252-8.
48. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC. A novel interaction of outer membrane protein A with C4b-binding protein mediates serum resistance of Escherichia coli K1. J Immunol 2002; 169: 6352-60.
49. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287-91.
50. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995; 21: 897-904.
51. Meri T, Hartmann A, Lenk D, Eck R, Wurzner R, Hellwage J, Meri S, Zipfel PF. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun 2002; 70: 5185-92.
52. Meri T, Blom AM, Hartmann A, Lenk D, Meri S, Zipfel PF. The yeast and hyphal forms of Candida albicans bind complement regulator C4b-binding protein. 2004; submitted.
53. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 1996; 60: 267-79.
54. Nordström T, Blom AM, Forsgren A K. R. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b-binding protein through ubiquitous surface proteins A1 and A2. 2004; submitted.
55. McMichael JC, Fiske MJ, Fredenburg RA, Chakravarti DN, VanDerMeid KR, Barniak V, Caplan J, Bortell E, Baker S, Arumugham R, Chen D. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun 1998; 66: 4374-81.
56. Spiller OB, Morgan BP, Tufaro F, Devine DV. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur J Immunol 1996; 26: 1532-8.
57. Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 1994; 205: 82-92.
58. Vanderplasschen A, Mathew E, Hollinshead M, Sim RB, Smith GL. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci USA 1998; 95: 7544-9.
59. Stoiber H, Schneider R, Janatova J, Dierich MP. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology 1995; 193: 98-113.
60. Lubinski J, Wang L, Mastellos D, Sahu A, Lambris JD, Friedman HM. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 1999; 190: 1637-46.
61. Rother RP, Rollins SA, Fodor WL, Albrecht JC, Setter E, Fleckenstein B, Squinto SP. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 1994; 68: 730-7.
62. Albrecht JC, Fleckenstein B. New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 1992; 66: 3937-40.
63. Kapadia SB, Molina H, van Berkel V, Speck SH, Virgin HWt. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 1999; 73: 7658-70.
64. Kapadia SB, Levine B, Speck SH, Virgin HW. Critical role of complement and viral evasion of complement in acute, persistent, and latent g-herpesvirus infection. Immunity 2002; 17: 143-55.
65. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862-7.
66. Spiller BO, Robinson M, O'Donnell E, Milligan S, Morgan PB, Davison AJ, Blackbourn DJ. Complement regulation by Kaposi's sarcoma-associated herpesvirus. J Virol 2003; 77: 592-9.
67. Spiller BO, Blackbourne D, Mark L, Proctor D, Blom AM. Functional activity of the complement regulator encoded by Kaposis's sarcoma associated herpesvirus. J Biol Chem 2003; 278: 9283-9.
68. Blom AM, Kask L, Ramesh B, Hillarp A. Regulation of factor I cofactor activity of C4b-protein and factor H by zinc. Arch Biochem Biophys 2003; 418: 108-18.
69. Isenman DE, Kells DIC, Cooper NR, Muller-Eberhard HJ, Pangburn MK. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 1981; 20: 4458-67.
70. Isenman DE. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme Factor I and its cofactor H. J Biol Chem 1983; 258: 4238-44.
71. Andonova M, Borissov I, Sotirov L. Changes in some factors of the innate immunity and serum zinc and iron concentrations in pigs following intravenous administration of Escherichia coli lipopolysaccharide. Onderstepoort J Vet Res 2001; 68: 91-9.
72. Dalekos GN, Ringstad J, Savaidis I, Seferiadis KI, Tsianos EV. Zinc, copper and immunological markers in the circulation of well nourished patients with ulcerative collitis. Eur J Gastroent Hepat 1998; 10: 331-7.
73. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998; 19: 556-61.
74. Gorodetzky R, Mou X, Blankenfeld A, Marx G. Platelet multielemental composition, lability, and subcellular localization. Am J Hematol 1993; 42: 278-83.
75. Bush AI, Pettingell WH, Paradis M, Tanzi RE. Modulation of Ab adhesiveness and secretase site cleavage by zinc. J Biol Chem 1994; 269: 12152-8.
76. Chia SE, Ong CN, Chua LH, Ho LM, Tay SK. Comparison of zinc concentrations in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J Androl 2000; 21: 53-7.
77. Brodbeck WG, Liu D, Sperry J, Mold C, Medof ME. Localization of classical and alternative pathway regulatory activity within the decay accelerating factor. J Immunol 1996; 156: 2528-33.
78. Adams EM, Brown MC, Nunge M, Krych M, Atkinson JP J Immunol 1991; 147: 3005-11.
79. Iwata K, Seya T, Yanagi Y, Pesando Jm, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S. J Biol Chem 1995; 270: 15148-52.
80. Alsenz J, Lambris JD, Schulz TF, Dierich MP Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H. Biochem J 1984; 224: 389-98.
81. Gordon DL, Kaufman RM, Blackmore TK, Kwong J, Lublin DM. Identification of complement regulatory domains in human factor H. J Immunol 1995; 155: 348-56.
82. Kuhn S, Skerka C, Zipfel PF. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J Immunol 1995; 155: 5663-70.
83. Kuhn S, Zipfel PF. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur J Immunol 1996; 26: 2383-7.
84. Jokiranta TS, Hellwage J, Koistinen V, Zipfel PF, Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem 2000; 275: 27657-62.
85. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med 1988; 168: 1699-717.
86. Krych M, Hourcade D, Atkinson JP. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci USA 1991; 88: 4353-7.
87. Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem 1994; 269: 13273-8.
88. Krych M, Hauhart R, Atkinson JP. Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem 1998; 273: 8623-9.
89. Blom AM, Kask L, Dahlbäck B. CCP1-4 of the C4b-binding protein α-chain are required for Factor I mediated cleavage of C3b. Mol Immunol 2003; 39: 547-56.
90. Johnsson E, Thern A, Dahlbäck B, Heden LO, Wikström M, Lindahl G. Human C4BP binds to the hypervariable N-terminal region of many members in the streptococcal M protein family. Adv Exp Med Biol 1997; 418: 505-10.
91. Blom AM, Villoutreix BO, Dahlbäck B. Complement inhibitor C4b-binding protein - friend or foe in the innate immune system? Mol Immunol 2004; 40: 1333-46.